Lunsekimig, a bispecific drug aimed at two popular targets, succeeded in studies in asthma and nasal polyps but missed its mark in an eczema trial.

Abstract: Phased array-based systems must support the formation of beams with precise lobes and nulls in specific locations to operate effectively in complex environments with multiple users, objects, ...

"Section 232" national security levies won't apply to a wide array of drugs, meaning the "overall threat to the sector should ...

Colorado drugmaker Ambrosia Biosciences has landed $100 million to pursue an oral obesity drug it’s hoping can compete with a ...

Zee Business provides the latest business news such as Indian stock market news and Updates, sensex live news & nifty news. Check out the personal finance news from the world of business including BSE ...

Presented at ASCO Annual Meeting, virtual, May 29-31, 2020; World Congress on Lung Cancer, virtual, January 28-31, 2021; ASCO Annual Meeting, virtual, June 4-8, 2021 ...

BEIJING, March 25, 2026 /PRNewswire/ -- LakeShore Biopharma Co., Ltd ("LakeShore Biopharma" or the "Company") (OTCPK: LSBCF; OTCPK: LSBWF), a global biopharmaceutical company dedicated to discovering, ...

March 24 (Reuters) - Spanish drugmaker Grifols (GRLS.MC), opens new tab said on Tuesday it has approved a U.S. initial ‌public offering of its U.S. biopharma business. Grifols, which makes drugs using ...

The readout for Firmonertinib has moved to mid-2026, which may reflect slower event accumulation and potentially longer progression-free survival compared with the current standard of care. If the ...

March 24 (Reuters) - Spanish drugmaker Grifols said on Tuesday it has approved a U.S. initial public offering of its U.S. biopharma business. Grifols, which makes drugs using blood plasma, plans to ...

Announced strategic collaboration and license agreement with ImmunoScape to develop breakthrough cell therapy approach for solid tumors – Entitled to receive upfront payments totaling $15M BOSTON, ...